| 发明名称 |
EMESIS TREATMENT |
| 摘要 |
A method of treating or preventing emesis through the administration of an effective dosage of a 2-(amino)tetralin compound in which one of the S or R enantiomers of the 2-(amino) tetralin compound is present in the composition in excess of the other enantiomer, and compositions comprising such a 2-(amino)tetralin compound in which the ratio of the S and R enantiomers is at least 2:1. |
| 申请公布号 |
US2015005388(A1) |
申请公布日期 |
2015.01.01 |
| 申请号 |
US201414447518 |
申请日期 |
2014.07.30 |
| 申请人 |
Epiomed Therapeutics, Inc. |
发明人 |
Helton David;Lucot James |
| 分类号 |
A61K31/135 |
主分类号 |
A61K31/135 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method for the treatment of emesis in a mammal, comprising the step of administering to the mammal a composition comprising S(−)-8-hydroxy-2-(dipropylamino)tetralin and R(+)-8-hydroxy-2-(dipropylamino)tetralin, wherein the ratio of S(−)-8-hydroxy-2-(dipropylamino)tetralin to R(+)-8-hydroxy-2-(dipropylamino)tetralin present in the composition is at least 4:1. |
| 地址 |
Laguna Hills CA US |
